ID   MUSK_RAT                Reviewed;         868 AA.
AC   Q62838;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 177.
DE   RecName: Full=Muscle, skeletal receptor tyrosine protein kinase;
DE            EC=2.7.10.1;
DE   AltName: Full=Muscle-specific tyrosine protein kinase receptor;
DE            Short=MuSK;
DE            Short=Muscle-specific kinase receptor;
DE   Flags: Precursor;
GN   Name=Musk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND
RP   INDUCTION BY DENERVATION.
RC   TISSUE=Muscle;
RX   PubMed=7546737; DOI=10.1016/0896-6273(95)90146-9;
RA   Valenzuela D.M., Stitt T.N., DiStefano P.S., Rojas E., Mattsson K.,
RA   Compton D.L., Nunez L., Park J.S., Stark J.L., Gies D.R., Thomas S.,
RA   LeBeau M.M., Fernald A.A., Copeland N.G., Jenkins N.A., Burden S.J.,
RA   Glass D.J., Yancopoulos G.D.;
RT   "Receptor tyrosine kinase specific for the skeletal muscle lineage:
RT   expression in embryonic muscle, at the neuromuscular junction, and after
RT   injury.";
RL   Neuron 15:573-584(1995).
RN   [2]
RP   FUNCTION IN MEMORY FORMATION.
RX   PubMed=16870737; DOI=10.1523/jneurosci.1674-06.2006;
RA   Garcia-Osta A., Tsokas P., Pollonini G., Landau E.M., Blitzer R.,
RA   Alberini C.M.;
RT   "MuSK expressed in the brain mediates cholinergic responses, synaptic
RT   plasticity, and memory formation.";
RL   J. Neurosci. 26:7919-7932(2006).
RN   [3]
RP   INTERACTION WITH LRP4.
RX   PubMed=18848351; DOI=10.1016/j.cell.2008.10.002;
RA   Kim N., Stiegler A.L., Cameron T.O., Hallock P.T., Gomez A.M., Huang J.H.,
RA   Hubbard S.R., Dustin M.L., Burden S.J.;
RT   "Lrp4 is a receptor for Agrin and forms a complex with MuSK.";
RL   Cell 135:334-342(2008).
RN   [4]
RP   INTERACTION WITH DNAJA3.
RX   PubMed=19038220; DOI=10.1016/j.neuron.2008.09.025;
RA   Linnoila J., Wang Y., Yao Y., Wang Z.Z.;
RT   "A mammalian homolog of Drosophila tumorous imaginal discs, Tid1, mediates
RT   agrin signaling at the neuromuscular junction.";
RL   Neuron 60:625-641(2008).
RN   [5]
RP   INTERACTION WITH DOK7, ACTIVITY REGULATION, AND PHOSPHORYLATION AT TYR-754.
RX   PubMed=20603078; DOI=10.1016/j.molcel.2010.06.007;
RA   Bergamin E., Hallock P.T., Burden S.J., Hubbard S.R.;
RT   "The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine
RT   kinase MuSK via dimerization.";
RL   Mol. Cell 39:100-109(2010).
RN   [6]
RP   FUNCTION, INTERACTION WITH DOK7, PHOSPHORYLATION, AND MUTAGENESIS OF
RP   VAL-789 AND MET-834.
RX   PubMed=23326516; DOI=10.1371/journal.pone.0053826;
RA   Ben Ammar A., Soltanzadeh P., Bauche S., Richard P., Goillot E., Herbst R.,
RA   Gaudon K., Huze C., Schaeffer L., Yamanashi Y., Higuchi O., Taly A.,
RA   Koenig J., Leroy J.P., Hentati F., Najmabadi H., Kahrizi K., Ilkhani M.,
RA   Fardeau M., Eymard B., Hantai D.;
RT   "A mutation causes MuSK reduced sensitivity to agrin and congenital
RT   myasthenia.";
RL   PLoS ONE 8:E53826-E53826(2013).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 560-860.
RX   PubMed=12220490; DOI=10.1016/s0969-2126(02)00814-6;
RA   Till J.H., Becerra M., Watty A., Lu Y., Ma Y., Neubert T.A., Burden S.J.,
RA   Hubbard S.R.;
RT   "Crystal structure of the MuSK tyrosine kinase: insights into receptor
RT   autoregulation.";
RL   Structure 10:1187-1196(2002).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.21 ANGSTROMS) OF 22-212, FUNCTION,
RP   PHOSPHORYLATION, SUBUNIT, SUBCELLULAR LOCATION, MUTAGENESIS OF MET-48;
RP   LEU-83 AND ILE-96, AND DISULFIDE BONDS.
RX   PubMed=17011580; DOI=10.1016/j.jmb.2006.09.019;
RA   Stiegler A.L., Burden S.J., Hubbard S.R.;
RT   "Crystal structure of the agrin-responsive immunoglobulin-like domains 1
RT   and 2 of the receptor tyrosine kinase MuSK.";
RL   J. Mol. Biol. 364:424-433(2006).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 313-494, SUBUNIT, DISULFIDE BONDS,
RP   AND GLYCOSYLATION AT ASN-338.
RX   PubMed=19664639; DOI=10.1016/j.jmb.2009.07.091;
RA   Stiegler A.L., Burden S.J., Hubbard S.R.;
RT   "Crystal structure of the frizzled-like cysteine-rich domain of the
RT   receptor tyrosine kinase MuSK.";
RL   J. Mol. Biol. 393:1-9(2009).
CC   -!- FUNCTION: Receptor tyrosine kinase which plays a central role in the
CC       formation and the maintenance of the neuromuscular junction (NMJ), the
CC       synapse between the motor neuron and the skeletal muscle
CC       (PubMed:23326516). Recruitment of AGRIN by LRP4 to the MUSK signaling
CC       complex induces phosphorylation and activation of MUSK, the kinase of
CC       the complex. The activation of MUSK in myotubes regulates the formation
CC       of NMJs through the regulation of different processes including the
CC       specific expression of genes in subsynaptic nuclei, the reorganization
CC       of the actin cytoskeleton and the clustering of the acetylcholine
CC       receptors (AChR) in the postsynaptic membrane. May regulate AChR
CC       phosphorylation and clustering through activation of ABL1 and Src
CC       family kinases which in turn regulate MUSK. DVL1 and PAK1 that form a
CC       ternary complex with MUSK are also important for MUSK-dependent
CC       regulation of AChR clustering. May positively regulate Rho family
CC       GTPases through FNTA. Mediates the phosphorylation of FNTA which
CC       promotes prenylation, recruitment to membranes and activation of RAC1 a
CC       regulator of the actin cytoskeleton and of gene expression. Other
CC       effectors of the MUSK signaling include DNAJA3 which functions
CC       downstream of MUSK. May also play a role within the central nervous
CC       system by mediating cholinergic responses, synaptic plasticity and
CC       memory formation. {ECO:0000269|PubMed:16870737,
CC       ECO:0000269|PubMed:17011580, ECO:0000269|PubMed:23326516}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O15146};
CC   -!- ACTIVITY REGULATION: Positively regulated by CK2. {ECO:0000250}.
CC   -!- SUBUNIT: Monomer (By similarity). Homodimer (Probable). Interacts with
CC       LRP4; the heterodimer forms an AGRIN receptor complex that binds AGRIN
CC       resulting in activation of MUSK. Forms a heterotetramer composed of 2
CC       DOK7 and 2 MUSK molecules which facilitates MUSK trans-
CC       autophosphorylation on tyrosine residue and activation. Interacts (via
CC       cytoplasmic part) with DOK7 (via IRS-type PTB domain); requires MUSK
CC       phosphorylation. Interacts with DVL1 (via DEP domain); the interaction
CC       is direct and mediates the formation of a DVL1, MUSK and PAK1 ternary
CC       complex involved in AChR clustering (By similarity). Interacts with
CC       PDZRN3; this interaction is enhanced by agrin (By similarity).
CC       Interacts with FNTA; the interaction is direct and mediates AGRIN-
CC       induced phosphorylation and activation of FNTA (By similarity).
CC       Interacts with CSNK2B; mediates regulation by CK2 (By similarity).
CC       Interacts (via the cytoplasmic domain) with DNAJA3. Interacts with NSF;
CC       may regulate MUSK endocytosis and activity (By similarity). Interacts
CC       with CAV3; may regulate MUSK signaling (By similarity). Interacts with
CC       RNF31 (By similarity). Interacts with DOK7 (PubMed:23326516).
CC       {ECO:0000250, ECO:0000269|PubMed:23326516, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000305|PubMed:17011580}; Single-pass type I membrane protein
CC       {ECO:0000305|PubMed:17011580}. Note=Localizes to the postsynaptic cell
CC       membrane of the neuromuscular junction. {ECO:0000250|UniProtKB:O15146,
CC       ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Muscle specific. {ECO:0000269|PubMed:7546737}.
CC   -!- DEVELOPMENTAL STAGE: From 14.0 dpc, expressed in developing myotomes.
CC       Once the muscle is innervated, localized to the neuromuscular junction
CC       (NMJ), where its expression is restricted to synaptic nuclei.
CC       Expression drops after birth. {ECO:0000269|PubMed:7546737}.
CC   -!- INDUCTION: Up-regulated upon denervation (at protein level).
CC       {ECO:0000269|PubMed:7546737}.
CC   -!- PTM: Ubiquitinated by PDZRN3. Ubiquitination promotes endocytosis and
CC       lysosomal degradation (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated (PubMed:23326516). Phosphorylation is induced by
CC       AGRIN in a LRP4-dependent manner (PubMed:23326516). Autophosphorylated
CC       (By similarity). Autophosphorylation at Tyr-553 is required for
CC       interaction with DOK7 which in turn stimulates the phosphorylation and
CC       the activation of MUSK (By similarity). {ECO:0000250|UniProtKB:Q61006,
CC       ECO:0000269|PubMed:23326516}.
CC   -!- PTM: Neddylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U34985; AAA90956.1; -; mRNA.
DR   RefSeq; NP_112323.1; NM_031061.1.
DR   PDB; 1LUF; X-ray; 2.05 A; A=529-868.
DR   PDB; 2IEP; X-ray; 2.21 A; A/B=22-212.
DR   PDB; 3HKL; X-ray; 2.10 A; A/B=313-494.
DR   PDBsum; 1LUF; -.
DR   PDBsum; 2IEP; -.
DR   PDBsum; 3HKL; -.
DR   AlphaFoldDB; Q62838; -.
DR   SMR; Q62838; -.
DR   IntAct; Q62838; 7.
DR   MINT; Q62838; -.
DR   STRING; 10116.ENSRNOP00000041075; -.
DR   GlyCosmos; Q62838; 3 sites, No reported glycans.
DR   GlyGen; Q62838; 3 sites.
DR   iPTMnet; Q62838; -.
DR   PhosphoSitePlus; Q62838; -.
DR   PaxDb; 10116-ENSRNOP00000041075; -.
DR   GeneID; 81725; -.
DR   KEGG; rno:81725; -.
DR   UCSC; RGD:3211; rat.
DR   AGR; RGD:3211; -.
DR   CTD; 4593; -.
DR   RGD; 3211; Musk.
DR   eggNOG; KOG1026; Eukaryota.
DR   InParanoid; Q62838; -.
DR   OrthoDB; 1614410at2759; -.
DR   EvolutionaryTrace; Q62838; -.
DR   PRO; PR:Q62838; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0017147; F:Wnt-protein binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0090102; P:cochlea development; IEP:RGD.
DR   GO; GO:0007167; P:enzyme-linked receptor protein signaling pathway; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0007613; P:memory; IMP:RGD.
DR   GO; GO:0097049; P:motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:RGD.
DR   GO; GO:0007528; P:neuromuscular junction development; IEP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:2000673; P:positive regulation of motor neuron apoptotic process; ISO:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IBA:GO_Central.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IBA:GO_Central.
DR   GO; GO:2000541; P:positive regulation of protein geranylgeranylation; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:RGD.
DR   GO; GO:0035022; P:positive regulation of Rac protein signal transduction; ISO:RGD.
DR   GO; GO:1904395; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; ISO:RGD.
DR   GO; GO:0045887; P:positive regulation of synaptic assembly at neuromuscular junction; IMP:RGD.
DR   GO; GO:0032224; P:positive regulation of synaptic transmission, cholinergic; IMP:RGD.
DR   GO; GO:0043113; P:receptor clustering; IMP:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0008582; P:regulation of synaptic assembly at neuromuscular junction; ISS:UniProtKB.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IMP:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEP:RGD.
DR   GO; GO:0071340; P:skeletal muscle acetylcholine-gated channel clustering; ISO:RGD.
DR   CDD; cd07469; CRD_TK_ROR_related; 1.
DR   CDD; cd20970; IgI_1_MuSK; 1.
DR   CDD; cd20968; IgI_2_MuSK; 1.
DR   CDD; cd05050; PTKc_Musk; 1.
DR   Gene3D; 1.10.2000.10; Frizzled cysteine-rich domain; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR036790; Frizzled_dom_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   PANTHER; PTHR24416:SF317; MUSCLE, SKELETAL RECEPTOR TYROSINE-PROTEIN KINASE; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF01392; Fz; 1.
DR   Pfam; PF07679; I-set; 3.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF000615; TyrPK_CSF1-R; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Developmental protein;
KW   Differentiation; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Kinase; Magnesium; Membrane; Metal-binding; Muscle protein;
KW   Nucleotide-binding; Phosphoprotein; Postsynaptic cell membrane; Receptor;
KW   Reference proteome; Repeat; Signal; Synapse; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..868
FT                   /note="Muscle, skeletal receptor tyrosine protein kinase"
FT                   /id="PRO_0000024448"
FT   TOPO_DOM        22..494
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        495..515
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        516..868
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..116
FT                   /note="Ig-like 1"
FT   DOMAIN          121..205
FT                   /note="Ig-like 2"
FT   DOMAIN          212..302
FT                   /note="Ig-like 3"
FT   DOMAIN          312..450
FT                   /note="FZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DOMAIN          574..855
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        724
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         580..588
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         608
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         553
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q61006"
FT   MOD_RES         680
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q61006"
FT   MOD_RES         697
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q61006"
FT   MOD_RES         754
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20603078"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        338
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19664639"
FT   CARBOHYD        459
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..99
FT   DISULFID        98..112
FT   DISULFID        142..190
FT   DISULFID        233..282
FT                   /evidence="ECO:0000250"
FT   DISULFID        317..382
FT   DISULFID        325..375
FT   DISULFID        366..406
FT   DISULFID        394..447
FT   DISULFID        398..434
FT   MUTAGEN         48
FT                   /note="M->R: Strongly reduced agrin-dependent activation
FT                   and autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:17011580"
FT   MUTAGEN         83
FT                   /note="L->R: Abolishes agrin-dependent activation and
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:17011580"
FT   MUTAGEN         96
FT                   /note="I->A: Abolishes agrin-dependent activation and
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:17011580"
FT   MUTAGEN         789
FT                   /note="V->M: Reduces interaction with DOK7."
FT                   /evidence="ECO:0000269|PubMed:23326516"
FT   MUTAGEN         834
FT                   /note="M->V: Reduces LRP4- and AGRIN-dependent
FT                   phosphorylation. Reduces DOK7-dependent phosphorylation.
FT                   Reduces agrin-dependent AChR aggregation in neuromuscular
FT                   junction. Reduces interaction with DOK7."
FT                   /evidence="ECO:0000269|PubMed:23326516"
FT   STRAND          26..32
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          36..40
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          45..48
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          51..55
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          58..63
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          75..78
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   HELIX           79..81
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          83..88
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          95..102
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          109..125
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          130..133
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          138..140
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          143..148
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          151..156
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          165..169
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          175..179
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   HELIX           182..184
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          186..194
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          197..200
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          204..209
FT                   /evidence="ECO:0007829|PDB:2IEP"
FT   STRAND          315..318
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   STRAND          323..325
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   TURN            326..328
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   STRAND          335..338
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   STRAND          341..343
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   HELIX           344..359
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   TURN            364..366
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   HELIX           367..378
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   STRAND          384..387
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   HELIX           395..403
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   TURN            404..409
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   HELIX           410..424
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   HELIX           434..436
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   TURN            440..442
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   STRAND          446..448
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   TURN            451..453
FT                   /evidence="ECO:0007829|PDB:3HKL"
FT   HELIX           562..566
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           571..573
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          575..582
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          587..594
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          600..609
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           616..630
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          640..644
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          646..649
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          651..655
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           662..668
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           698..717
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           727..729
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          730..732
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           734..736
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   STRAND          738..740
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           746..749
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           751..753
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           765..767
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           770..775
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           780..795
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   TURN            796..798
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   TURN            801..804
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           807..815
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           828..837
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           842..844
FT                   /evidence="ECO:0007829|PDB:1LUF"
FT   HELIX           848..857
FT                   /evidence="ECO:0007829|PDB:1LUF"
SQ   SEQUENCE   868 AA;  96822 MW;  C146B4E74EE25B24 CRC64;
     MRELVNIPLL QMLTLVAFSG TEKLPKAPVI TTPLETVDAL VEEVATFMCA VESYPQPEIS
     WTRNKILIKL FDTRYSIREN GQLLTILSVE DSDDGIYCCT ANNGVGGAVE SCGALQVKMK
     PKITRPPINV KIIEGLKAVL PCTTMGNPKP SVSWIKGDSA LRENSRIAVL ESGSLRIHNV
     QKEDAGQYRC VAKNSLGTAY SKLVKLEVEV FARILRAPES HNVTFGSFVT LRCTAIGMPV
     PTISWIENGN AVSSGSIQEN VKDRVIDSRL QLFITKPGLY TCIATNKHGE KFSTAKAAAT
     VSIAEWSKSQ KESKGYCAQY RGEVCDAVLV KDSLVFFNTS YPDPEEAQEL LIHTAWNELK
     AVSPLCRPAA EALLCNHLFQ ECSPGVLPTP MPICREYCLA VKELFCAKEW LAMEGKTHRG
     LYRSGMHFLP VPECSKLPSM HQDPTACTRL PYLDYKKENI TTFPSITSSK PSVDIPNLPA
     STSSFAVSPA YSMTVIISIM SCFAVFALLT ITTLYCCRRR REWKNKKRES AAVTLTTLPS
     ELLLDRLHPN PMYQRMPLLL NPKLLSLEYP RNNIEYVRDI GEGAFGRVFQ ARAPGLLPYE
     PFTMVAVKML KEEASADMQA DFQREAALMA EFDNPNIVKL LGVCAVGKPM CLLFEYMAYG
     DLNEFLRSMS PHTVCSLSHS DLSTRARVSS PGPPPLSCAE QLCIARQVAA GMAYLSERKF
     VHRDLATRNC LVGENMVVKI ADFGLSRNIY SADYYKADGN DAIPIRWMPP ESIFYNRYTT
     ESDVWAYGVV LWEIFSYGLQ PYYGMAHEEV IYYVRDGNIL ACPENCPLEL YNLMRLCWSK
     LPADRPSFCS IHRILQRMCE RAEGTVGV
//
